Jingxin Pharmaceutical
Jingxin Pharmaceutical Co., Ltd., commonly referred to as Jingxin Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of cardiovascular, anti-infective, and central nervous system medications. With a strong operational presence across various regions in Asia and beyond, Jingxin Pharma is recognised for its commitment to quality and research-driven solutions. The company’s core offerings include a diverse range of generic and proprietary drugs, distinguished by their efficacy and safety profiles. Notably, Jingxin has achieved several industry certifications, reinforcing its market position as a trusted provider of healthcare solutions. Through continuous innovation and a focus on patient needs, Jingxin Pharmaceutical remains dedicated to enhancing global health outcomes.
DitchCarbon Score
How does Jingxin Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jingxin Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jingxin Pharmaceutical's reported carbon emissions
Jingxin Pharmaceutical, headquartered in China, currently does not have available carbon emissions data for the most recent year. However, the company has made commitments towards reducing its carbon footprint. Jingxin Pharmaceutical is classified as "Committed" to near-term reduction targets, although specific targets or timelines have not been disclosed. As part of the pharmaceutical, biotechnology, and life sciences sector, Jingxin Pharmaceutical is expected to align with industry standards for climate action, focusing on reducing emissions across various scopes. While there are no specific figures provided for Scope 1, 2, or 3 emissions, the company's commitment indicates a proactive approach to addressing climate change. In summary, while detailed emissions data is lacking, Jingxin Pharmaceutical is taking steps towards sustainability through its commitment to reduction targets, reflecting a growing trend within the industry to prioritise environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jingxin Pharmaceutical is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
